ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,150.00
-0.67%
S&P ASX All Technology
3,461.90
-0.11%
Brent Oil
77.97
0.00%
US Dollar vs AUD
1.47145
0.00%
Bitcoin
61,901.93
-0.28%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Quoin Pharmaceuticals Ltd (QNRX) Share Price

Quoin Pharmaceuticals Ltd

Quoin Pharmaceuticals Ltd (QNRX)

NASDAQ
0.4839
-0.0035
(-0.72%)
Closed 06 October 7:00AM
Delayed by 15 minutes
0.485
0.0011
(0.23%)
After Hours: 9:54AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.485
Bid
0.485
Offer
0.49
Volume
32,633
0.481 Day's Range 0.492
0.00 52 Week Range 0.00
Market Cap
1.93M
Previous Close
0.4874
Open
0.491
Last Trade
811
@
0.485
(formt)
Last Trade Time
Financial Volume
US$ 15,880
VWAP
0.486611
Average Volume (3m)
-
Shares Outstanding
3,979,970
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
-
Net Profit
-8.69M

About Quoin Pharmaceuticals Ltd

Quoin Pharmaceuticals Ltd is a pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Neth... Quoin Pharmaceuticals Ltd is a pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others. Show more

Sector
Medicinal Chems,botanicl Pds
Industry
Cmp Programming,data Process
Website
www.cellect.co
Headquarters
Kfar Saba, Center, Isr
Founded
2007
Quoin Pharmaceuticals Ltd is listed in the Medicinal Chems,botanicl Pds sector of the NASDAQ with ticker QNRX. The last closing price for Quoin Pharmaceuticals was US$0.49. Over the last year, Quoin Pharmaceuticals shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Quoin Pharmaceuticals currently has 3,979,970 shares in issue. The market capitalisation of Quoin Pharmaceuticals is US$1.94 million.

Ask ADVFN Intelligence (AI)

QNRX Latest News

More News

Form 8-K - Current report

30 September 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

12 September 2024
Edgar (US Regulatory)

Quoin Pharmaceuticals Announces Insider Share Purchases by Co-Founders CEO and COO

ASHBURN, Va., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals (NASDAQ: QNRX), a clinical stage, specialty pharmaceutical company focused on developing and commercializing novel...

09 September 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

06 September 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

06 September 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

13 August 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

09 August 2024
Edgar (US Regulatory)

Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2024 Financial Results

Quoin Broadens Product Portfolio through Research Agreement with University College Cork, Ireland Company Expands On-going Clinical Trials in Netherton Syndrome to Include International Sites...

08 August 2024
GlobeNewswire Inc.

Quoin Pharmaceuticals to Initiate Clinical Study for Peeling Skin Syndrome

Peeling Skin Syndrome is a rare autosomal disease with no approved treatment or cure Initial clinical site and pediatric patient identified in New Zealand Company actively evaluating opening...

06 August 2024
GlobeNewswire Inc.

Quoin Pharmaceuticals to Announce Second Quarter 2024 Financial Results on Thursday, August 8, 2024

ASHBURN, Va., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage specialty pharmaceutical company focused on rare and orphan...

02 August 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CHSNChanson International Holding
US$ 11.22
(269.08%)
14.76M
PEVPhoenix Motor Inc
US$ 1.0607
(205.24%)
228.42M
ENTOEntero Therapeutics Inc
US$ 0.60
(72.20%)
10.42M
BENFBeneficient
US$ 1.8914
(58.94%)
108.31M
FORDForward Industries Inc
US$ 5.3254
(52.15%)
18.45M
ADDColor Star Technology Company Ltd
US$ 0.2701
(-39.98%)
15.01M
DUOFangDD Network Group Ltd
US$ 2.53
(-32.89%)
28.52M
ICCTiCoreConnect Inc
US$ 0.4102
(-31.50%)
1.68M
ZENAZenaTech Inc
US$ 3.91
(-29.55%)
213.24k
SPAISafe Pro Group Inc
US$ 1.93
(-25.77%)
239.89k
NVDANVIDIA Corporation
US$ 124.92
(1.68%)
244.46M
PEVPhoenix Motor Inc
US$ 1.0607
(205.24%)
228.42M
SQQQProShares UltraPro Short QQQ
US$ 7.43
(-3.63%)
184.47M
NCNCnoco noco Inc
US$ 0.144
(8.60%)
147.38M
BENFBeneficient
US$ 1.8914
(58.94%)
108.31M

QNRX Discussion

View Posts
glenn1919 glenn1919 4 weeks ago
QNRX................................https://stockcharts.com/h-sc/ui?s=QNRX&p=W&b=5&g=0&id=p86431144783
👍️0
Awl416 Awl416 4 weeks ago
Quoin Pharmaceuticals Announces Insider Share Purchases by Co-Founders CEO and COO
👍️0
Disquisition Disquisition 6 months ago
UNYIELDING DUMPING
👍️0
Disquisition Disquisition 6 months ago
INCONTROVERTIBLE DUMPING
👍️0
Monksdream Monksdream 6 months ago
QNRX new 52 lo
👍️0
Monksdream Monksdream 7 months ago
Israeli stonk
👍️0
Stock_Gambit Stock_Gambit 7 months ago
Under $1….I wonder how that offering went lol
👍️0
Monksdream Monksdream 7 months ago
QNRX new 52 week low
👍️0
Disquisition Disquisition 7 months ago
bought 25,000 shares at 1.14 average

ready to DUMP after the CC tomorrow morning
👍️0
Monksdream Monksdream 7 months ago
QNRX new 52 lo
👍️0
Disquisition Disquisition 7 months ago
This is perhaps the best explanation of the share price action here I have ever heard
👍️0
Monksdream Monksdream 7 months ago
Dilution too little money chasing too many shares
👍️0
Stock_Gambit Stock_Gambit 7 months ago
I’m not sure how to read those filings. Did they get all they were looking for in that offering? Seems weird $1.60 a share and this is barely holding $1.20
👍️0
Monksdream Monksdream 7 months ago
QNRX 10Q due March 12
👍️0
Monksdream Monksdream 7 months ago
Israeli stonks are notorious for pump and dumps
A pump will begin two nanoseconds after the moomoo session opens for orders at 4am when it’s 11am in Tel Aviv
How long the pump lasts varies
Others may disagree with what I think is the usual senario for Israeli stonks
QNRX was done well before the 7am platforms open for orders
Sometimes the pump can continue after 7am when it’s 2pm in Tel Aviv
Most times, though put a for in it it’s done and the Tel Aviv players go out for dinner
👍️0
Stock_Gambit Stock_Gambit 7 months ago
I got some more 19’s. I don’t think an offering at 1.60 was issued for no reason. Insiders think this is going higher. Hit $2’s premarket.

I think we can see a nice move. We will see
👍️0
Stock_Gambit Stock_Gambit 7 months ago
Not bad. This can run.
👍️0
Monksdream Monksdream 7 months ago
I think it did
👍️0
Stock_Gambit Stock_Gambit 7 months ago
Did this hit $2 in premarket?
👍️0
Monksdream Monksdream 7 months ago
Wash trade bot running
👍️0
Monksdream Monksdream 7 months ago
Wash trade bot running
👍️0
Stock_Gambit Stock_Gambit 7 months ago
Thanks. Curious to see what happens. This ran to $6 recently
👍️0
Monksdream Monksdream 7 months ago
No, to create a wash trade run
👍️0
Stock_Gambit Stock_Gambit 7 months ago
Is that just to drop the stock?
👍️0
Monksdream Monksdream 7 months ago
Hong Kong, mainland Chinese, and Malaysian stonks are notorious for announcing an offering and then withdrawing it
👍️0
Stock_Gambit Stock_Gambit 7 months ago
What does that mean if they withdraw? It runs?
👍️0
Monksdream Monksdream 7 months ago
You just might
And then this Israeli stonk witndraws the offering and it sets off a wash trade bot rally
👍️0
Stock_Gambit Stock_Gambit 7 months ago
Offering closes tomorrow…. Wonder what happens to the price. We gonna see $1 and under?
👍️0
Monksdream Monksdream 7 months ago
QNRX new 52 week low
👍️0
ErnieBilco ErnieBilco 7 months ago
Bid sitting at .94 - I always bid 30-50% off offering price. Either it comes to me or I pass.
👍️0
Stock_Gambit Stock_Gambit 7 months ago
It would be crazy if this goes to .28 again after the split
👍️0
Stock_Gambit Stock_Gambit 7 months ago
Looks like they are going to do a rinse and repeat.
👍️0
Stock_Gambit Stock_Gambit 7 months ago
Maybe $1 is coming
👍️0
Stock_Gambit Stock_Gambit 7 months ago
This is lower than what the offering is. Why wouldn’t anyone just buy open market??
👍️0
Awl416 Awl416 7 months ago
Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome Clinical Studies
👍️0
TheFinalCD TheFinalCD 7 months ago
$QNRX Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome Clinical Studies $QNRX https://t.co/gVQbnnmOKC— Health Stocks News (@health_stocks) March 4, 2024
👍️0
Monksdream Monksdream 7 months ago
QNRX new 52 week low
👍️0
Monksdream Monksdream 8 months ago
QNRX new 52 week low
👍️0
Monksdream Monksdream 8 months ago
QNRX new 52 week low
👍️0
ErnieBilco ErnieBilco 11 months ago
What difference does it make? You gotta own 60K shares just to be left with one.

Sht like this doesn't even happen on the stinky pinkies, I'd like to know how these crooks are not in jail and even more concerning is that NASDAQ leaves it listed - Shows Nasdaq is just a more expensive scam operation than pinks
👍️0
BrownHole Capital BrownHole Capital 11 months ago
Do we know what they are doing with fractional shares leftover after the split?
👍️0
ErnieBilco ErnieBilco 1 year ago
My god man WTF are these theives thinking?

increase our registered
share capital from 500,000,000,000 ordinary shares, no par value, to 6,000,000,000,000 ordinary shares, no par value;
3. To adopt an amendment of our Articles of Association to effect a reverse split of our ordinary shares at a ratio of 1-for-60,000

Increase shares from 500 BILLION TO 6 TRILLION AND PULL A 60k TO 1 REVERSE THEFT?
👍️0
alwaysadaylate alwaysadaylate 1 year ago
Trying to time this bag of garbage before the bag rips and lose everything lol I need some hel Beijing what we gonna do?????
👍️0
Awl416 Awl416 1 year ago
Woooot wooot
👍️0
Awl416 Awl416 1 year ago
LOL shorts
👍️0
Awl416 Awl416 1 year ago
Don’t fuck with algo’s
👍️0
Awl416 Awl416 1 year ago
Now algo’s have it at penny. Scary
👍️0
Awl416 Awl416 1 year ago
.28 cents now
👍️0
Awl416 Awl416 1 year ago
The spread has varied from .02 to .42
👍️0
Awl416 Awl416 1 year ago
Fun to watch
👍️0

Your Recent History

NASDAQ
QNRX
Quoin Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved